GeneticsGenetic & Genomic MedicinePeer-reviewed journal article
How group structure impacts the numbers at risk for coronary artery disease: polygenic risk scores and non-genetic risk factors in the UK Biobank cohort
Abstract
The UK Biobank is a large cohort study that recruited over 500,000 British participants aged 40-69 in 2006-2010 at 22 assessment centres from across the UK. Self-reported health outcomes and hospital admission data are two types of records that include participants disease status. Coronary artery disease (CAD) is the most common cause of death in the UK Biobank cohort. After distinguishing between prevalence and incidence CAD events for all UK Biobank participants, we identified geographical variations in age-standardised rates of CAD between assessment centres. Significant distributional differences were found between the pooled cohort equation scores of UK Biobank participants from England and Scotland using the Mann-Whitney test. Polygenic risk scores of UK Biobank participants from England and Scotland and from different assessment centres differed significantly using permutation tests. Our aim was to discriminate between assessment centres with different disease rates by collecting data on disease-related risk factors. However, relying solely on individual-level predictions and averaging them to obtain group-level predictions proved ineffective, particularly due to the presence of correlated covariates resulting from participation bias. By using the Mundlak model, which estimates a random effects regression by including the group means of the independent variables in the model, we effectively addressed these issues. In addition, we designed a simulation experiment to demonstrate the functionality of the Mundlak model. Our findings have applications in public health funding and strategy, as our approach can be used to predict case rates in the future, as both population structure and lifestyle changes are uncertain.
- organism: human
- assay: bulk RNA-seq
- research focus: polygenic risk
- research focus: variant effect prediction
- research focus: benchmarking
- approach: statistical model
- approach: benchmark study
- Citations
- 3
- FWCI
- 0.79
- Field percentile
- top 32%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparison of polygenic risk scores for coronary artery disease highlights obstacles to overcome for clinical use
Holly Trochet, Justin Pelletier, … Julie Hussin·bioRxiv·Aug 9, 2020
- An integrated polygenic and clinical risk tool enhances coronary artery disease prediction
Fernando Riveros-Mckay, Michael E. Weale, … Peter Donnelly·Circulation Genomic and Precision MedicinePeer-reviewed·Mar 2, 2021
- Genomic risk prediction of coronary artery disease in nearly 500,000 adults: implications for early screening and primary prevention
Michael Inouye, Gad Abraham, … Nilesh J. Samani·bioRxiv·Jan 19, 2018
- Association of polygenic risk scores for coronary artery disease with subsequent events amongst established cases
Laurence J Howe, Frank Dudbridge, … Riyaz S. Patel·Human Molecular GeneticsPeer-reviewed·Mar 24, 2020
- Genetic risk score for coronary artery calcification predicts coronary artery disease beyond traditional risk factors
Pashupati Prasad Mishra, Binisha Hamal Mishra, … Terho J. Lehtimäki·medRxiv·Mar 27, 2024
- Population Performance and Individual Agreement of Coronary Artery Disease Polygenic Risk Scores
Sarah A. Abramowitz, Kristin M. Boulier, … Theodore G. Drivas·JAMAPeer-reviewed·Nov 16, 2024